REGN vs ZDGE · P/E 14, rev $4.29B vs rev $29.4M
Regeneron Pharmaceuticals Inc (REGN) versus Zedge Inc (ZDGE) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US. It is led by Leonard S. Schleifer M.D., Ph.D..
Zedge Inc (ZDGE) is a internet content & information company listed on US.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported ZDGE revenue for 2025-07-31 was $29.4M. Net income was -$2.4M. ZDGE currently screens at market cap $42.7M.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. ZDGE currently screens at market cap $42.7M.
Not investment advice. Open the REGN and ZDGE stock pages for the full models.
Not investment advice.